Structural

The Next Generation LAAC Device

CHAMPION AF and the Future of LAAC- More than a Bleeding Solution?

SIMPLAAFYing the Post-implant Drug Regimen

Next Generation LAAC Device Development

AMULET NG

Current Trials to Expand LAAC Clinical Indications

Keynote: The Case for Tandem or Staged AF Ablation and LAAC: Beyond OPTION

Antithrombotic Strategies After LAAC: What Are the Options?

Who’s the Right Patient? Interpreting Trials and Guidelines

Procedure Characteristics and Early Clinical Outcomes of LAAC Using a Novel Steerable Access System: A Sub-Analysis of HEAL-LAA

Vacuum-Based LACC by Invagination and Ligation (Append Medical)

Amulet NG: Clinical Program Update

Conformable Tension Free LAAC System (Conformal)

LAAC Outcomes in Patients with Prior Structural Heart Interventions

Can We Do Better? Next Generation LAAO Devices

AF Patients at Highest Bleeding Risks: How Should We Individualize Postimplant Medical Therapy?

Ultimate Stroke Prevention: LAAO in Association With Medical Therapy/Other Procedures

LAAO as First Line Stroke Prevention Therapy: Are CHAMPION-AF and CATALYST Trials Likely to Succeed?

No: The Transcatheter Devices Have Much Better Results

Yes: Based on LAAOS III, All LAA Should Be Ligated at the Time of Concurrent Heart Surgery

LAAO: Follow-up Postprocedural Imaging: CT Should Be the New Gold Standard

First-in-Human Experience with the Novel Watchman FLX Pro Device: Results of the Watchman FLX Pro CT study

US Early Feasibility Study Evaluating the Safety and Efficacy of Rotational Closure of the Left Atrial Appendage Using the Laminar Device in Patients with Non-Valvular Atrial Fibrillation

Percutaneous Left Atrial Appendage Closure Versus Chronic Oral Anticoagulation for Non-Valvular Atrial Fibrillation: An Individual Patient Data Level Meta-Analysis of Randomized Controlled Trials

Histomorphometric and Histopathologic Findings in Patients Undergoing Left Atrial Appendage Closure With Use of a Double-Filter Embolic Protection Device

Keynote Lecture: Which Anticoagulant or Antiplatelet Regimen Post LAAO - The Present and Future?

This Is the Way I Do Watchman FLX: Please Disagree With Every Single Step!

One-Year Outcomes after Amulet or Watchman/FLX Device for Percutaneous Left Atrial Appendage Closure: a Pre-Specified Analysis of the SWISS-APERO Randomized Clinical Trial

Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement - WATCH TAVR Trial Results

Present Devices to Future Solutions

The Next Generation of LAAC Device and Tailored Therapy

LAAC Safety: Current Data and Practices

Position 2: Hey… What About Creating an Atrial Shunt for Heart Failure

Novel LAAO Devices in the Pipeline

Left Atrial Appendage Closure with a Mapping Decapolar Catheter Utilizing a Jugular Vein Approach After Failed Femoral Vein Attempt

Innovative Use of PDA Amplatzer Devices for Occlusion of Small-Bore LA-LAA Communications Following Incomplete Surgical LAA Ligation

Con: Do We Have the Right Definitions for LAAO Success?

Pro: Go Big or Go Home: If in Doubt, You Should Oversize Your LAAO Device

The Future of LAAO? Pre and Intraprocedural CT Guidance

Case 2: Discordance Imaging: Sizing and Device Selection With Standard Imaging Resources (TEE or CTA)

Case 3: My Clinical and Anatomical Inclusion/Exclusion Criteria for Selecting Patients for ICE-Guided LAAO

The Olde Standards (Watchman Flex and Amulet)

New Kids on the Block! (LAmbre, Omega, Conformal, Laminar, …)

Developing a Successful LAAO Program – ‘Master Class’ Tips and Tricks

LAAO Technology Overview and Basic Procedural Do’s and Don’ts (Case Examples)

LAAC Device Surveillance: Significance of Peri-Device Leaks and Device-Related Thrombus

Amulet

Watchman Flex

LAAO vs DOACs: Ongoing Trials and My Prediction

Current FDA-Approved Devices: How to Select; Lesion-Specific Differences

LAA Closure Clinical Trial & Registry Update 2022

Ongoing Clinical Trials and the Future of LAAC